Lee, S.-E., Choi, S. Y., Song, H.-Y., Kim, S.-H., Choi, M.-Y., Park, J. S., Kim, H.-J., Kim, S.-H., Zang, D. Y., Oh, S., Kim, H., Do, Y. R., Kwak, J.-Y., Kim, J.-A., Kim, D.-Y., Mun, Y.-C., Lee, W. S., Chang, M. H., Park, J., Kwon, J. H. and Kim, D.-W. (2016) “Imatinib withdrawal syndrome and longer duration of imatinib have a close association with a lower molecular relapse after treatment discontinuation: the KID study”, Haematologica. Pavia, Italy, 101(6), pp. 717-723. doi: 10.3324/haematol.2015.139899.